loadpatents
Patent applications and USPTO patent grants for PAN; Wubin.The latest application filed is for "addition salt of s1p1 receptor agonist and crystal form thereof, and pharmaceutical composition".
Patent | Date |
---|---|
Addition Salt Of S1p1 Receptor Agonist And Crystal Form Thereof, And Pharmaceutical Composition App 20210230152 - ZHENG; Wei ;   et al. | 2021-07-29 |
Antibody For Binding To Interleukin 4 Receptor App 20210079088 - ZHENG; Wei ;   et al. | 2021-03-18 |
Antibody for binding to interleukin 4 receptor Grant 10,774,141 - Zheng , et al. Sept | 2020-09-15 |
Antibody For Binding To Interleukin 4 Receptor App 20200255514 - Kind Code | 2020-08-13 |
Antibody For Binding To Interleukin 4 Receptor App 20190177408 - ZHENG; Wei ;   et al. | 2019-06-13 |
Immune adjustment compound, use thereof and pharmaceutical composition comprising same Grant 10,280,158 - Zheng , et al. | 2019-05-07 |
Immune Adjustment Compound, Use Thereof And Pharmaceutical Composition Comprising Same App 20160347745 - ZHENG; Wei ;   et al. | 2016-12-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.